Disruption of this regulatory balance has been implicated in several gastrointestinal disorders, including inflammatory bowel disease, celiac disease, colorectal cancer, and malabsorption syndromes, where altered CYP24A1 activity may compromise epithelial barrier function, immune modulation, and nutrient transport. The gene discussed is CYP24A1; the disease is colorectal cancer.